The Interplay Between the Immune Cells and Microbial Dysbiosis in the Development of Endometriotic Lesions: Implications for Revisiting Hormonal and Surgical Treatments

In: SVOA Medical Research · 2026 · vol. 4(6) , pp. 210–226 · doi:10.58624/svoamr.2026.04.026 · W7226158374
Review OA: bronze CC0

Abstract

Endometriosis is a chronic, estrogen-dependent, inflammatory and fibrotic disease characterized by endometrial-like tissue outside the uterine cavity. Although retrograde menstruation explains the presence of endometrial fragments in the peritoneal cavity, it does not explain why only a subset of women develop persistent lesions, chronic pain or infertility. Increasing evidence indicates that endometriosis emerges from a permissive immunological and microbial ecosystem in which ectopic cells evade clearance, induce angiogenesis and neurogenesis, remodel extracellular matrix and sustain chronic inflammation. Immune abnormalities include macrophage expansion and M2-like polarization, impaired natural killer cell cytotoxicity, tolerogenic dendritic cells, altered neutrophil and mast-cell activity, Th17/Treg imbalance, exhausted cytotoxic T cells, B-cell activation and autoantibody production. In parallel, microbial dysbiosis in the gut, vagina, cervix, endometrium and peritoneal cavity may influence lesion biology through lipopolysaccharide/TLR4 activation, increased intestinal permeability, estrogen recycling by the estrobolome, short-chain fatty acid depletion, altered bile acid and tryptophan metabolism, and modulation of macrophage, NK-cell and T-cell phenotypes. This review explored the bidirectional immune-microbiota interactions that may drive the implantation, survival and progression of endometriotic lesions. We propose an “immune-microbial endocrine loop” in which dysbiosis amplifies inflammation and estrogenic signaling, while endometriotic lesions reshape local and systemic microbial niches. This paradigm has implications for current treatments. Hormonal suppression reduces estrogenic stimulation and symptoms but may not fully correct immune-microbial drivers. Surgery removes visible lesions but cannot necessarily reset the inflammatory microbiome or prevent recurrence. Revisiting hormonal and surgical strategies through an immune-microbial lens supports adjunctive approaches such as perioperative microbiome profiling, anti inflammatory nutrition, probiotics, postbiotics, selective antibiotics, estrobolome modulation, macrophage/ NK-cell-targeted therapy and personalized postoperative suppression. Robust longitudinal human studies and mechanism-based trials are required before microbiome-directed interventions can be routinely integrated into care.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (40)

Source provenance

openalex
last seen: 2026-11-22T06:06:27.128750+00:00
License: CC0 · commercial use OK